Development of human retina detailed in high-resolution atlas
May 11th 2023A team of researchers has now developed an approach to gather and compile a great deal of information about organoids and their development. The team applied its approach to the organoids of the human retina, which they derived from stem cells.
Read More
Researchers zero in on protecting the vision of premature babies
May 8th 2023Scientists at Medical College of Georgia demonstrated in their animal model of retinopathy of prematurity that the small molecule K604, which is being explored in cancer and Alzheimer’s, can block the development of leaky, obstructive blood vessels in the retina, tamp down inflammation and enable more normal blood vessel growth
Read More
ASCRS 2023: New head-to-head data show monofocal IOLs provide similar range of vision
May 7th 2023Alcon presented details from a new study at the American Society of Cataract and Refractive Surgery’s annual meeting taking place in San Diego, California. The investigator-initiated study led by J. Morgan Micheletti, MD, demonstrated that Clareon and Eyhance monofocal IOLs provide similar range of vision, including distance and intermediate visual acuity.
Read More
ASCRS 2023: Study of standalone multiple trabecular micro-bypass stents for uncontrolled glaucoma
May 6th 2023Ike Ahmed, MD, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss his presentation on the study of standalone multiple trabecular micro-bypass stents for uncontrolled glaucoma at the ASCRS annual meeting in San Diego
Read More
ASCRS 2023: Antibiotic resistance of intraocular bacterial pathogens
May 6th 2023Penny Asbell, MD, FACS, MBA, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss her presentation on the ARMOR study and the antibiotic resistance of intraocular bacterial pathogens at the ASCRS annual meeting in San Diego
Read More
David Wallace, MD, MPH, the Marilyn K. Glick Professor and chair of the Department of Ophthalmology for Indiana University School of Medicine, is new chairman of Ophthalmology and Visual Sciences and director of the Vanderbilt Eye Institute for Vanderbilt University Medical Center.
Read More
Study: AI cannot assist in preparing for ophthalmology board certification exams
May 5th 2023A study of ChatGPT found the artificial intelligence tool answered less than half of the test questions correctly from a study resource commonly used by physicians when preparing for board certification in ophthalmology.
Read More
According to the company, clinical trials of the ophthalmic gel showed that patients treated with IHEEZO did not require any supplemental treatment to complete the intended surgical procedure. Harrow will host several launch events at the 2023 American Society of Cataract and Refractive Surgery annual meeting being held May 5-8, 2023, in San Diego, California.
Read More
ASCRS 2023: Companies presenting clinical data and technology at annual meeting
May 4th 2023Eyecelerator kicks off today as the American Society of Cataract and Refractive Surgery will host this year’s ASCRS and ASOA Annual Meeting in San Diego, California, beginning on Friday. ViaLase Inc., Aurion Biotech among companies presenting at the annual meeting.
Read More
Horizon offers update on TED treatment option
May 4th 2023Horizon recently received an updated indication for TEPEZZA to specify its use in patients with TED, regardless of disease activity or duration, coming after the company released positive topline results from the phase four clinical trial of patients with chronic TED.
Read More
ARVO 2023: Implementing dropless cataract surgery to drop the cost
May 3rd 2023Ravi Parikh, MD, MPH, sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss his presentation about adopting dropless cataract surgery to help reduce cost to both patients and the healthcare system at this year's ARVO meeting.
Read More
ARVO 2023: Machine learning to identify structural phenotypes for glaucoma
May 3rd 2023Nazlee Zebardast, MD, MSc sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss her research on using machine learning methods to identify image-based, specifically OCT based, phenotypes or structural phenotypes for glaucoma. at this year's ARVO meeting.
Read More
ARVO 2023: ViaLase's FLigHT for non-incisional glaucoma treatment
May 3rd 2023Eric Mikula, PhD, from ViaLase sat down with David Hutton, Managing Editor, Ophthalmology Times®, to discuss the company's femtosecond laser image-guided high-precision trabeculectomy, FLigHT, for non-incisional glaucoma treatment at this year's ARVO meeting.
Read More
Ophthalmology professor to be inducted into Florida Inventors Hall of Fame
May 3rd 2023The Florida Inventors Hall of Fame is celebrating 10 years and will induct 10 inventors, including William W. Hauswirth, PhD, who developed a gene therapy drug to treat children and adults with inherited retinal disease.
Read More
ARVO LIVE: Using mitochondria, senolytic agents to treat retinal injury
May 3rd 2023Ram Kannan, PhD, FARVO, principal investigator and adjunct professor of Ophthalmology at David Geffen School of Medicine, UCLA, Doheny Eye Institute, made a pair of presentations at the Association for Research in Vision and Ophthalmology annual meeting in New Orleans. He offers some of the highlights in a conversation with Ophthalmology Times.
Read More